Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Feature

INC RESEARCH MOVES INTO NEW EUROPEAN HEADQUARTERS

Posted on: 20 Jan 05

Summary

INC RESEARCH MOVES INTO NEW EUROPEAN HEADQUARTERS TO ACCOMMODATE CONTINUING GLOBAL EXPANSION

Raleigh, North Carolina – January 17, 2005 - INC Research®, a global contract research organization (CRO) specialized in central nervous system (CNS), oncology and pediatric clinical research, announced today that the company has completed the relocation of its European headquarters and regional clinical office into a larger facility in Maidenhead, Berkshire, United Kingdom.  INC Research Europe has experienced over 100% growth in the past 12 months. The move to the new facility will accommodate both recent and projected growth. 

 

Kelvin Logan, President of INC Research Europe states, “The new location of our European headquarters, and additional expansion planned in Central, Eastern and Western Europe for 2005, will continue to provide us with a strategic advantage.  Of primary consideration is remaining in close proximity to existing and future customers, so we can more quickly provide responsive, quality service.  In addition, we can access a sizeable employee base of scientific and industry expertise, as well as specific patient populations critical to rapid execution of our customer’s clinical programs.”

 

The new facility is situated close to London’s Heathrow Airport and approximately 25 miles west of London at Vandervell House - Suite 220, Vanwall Business Park, Maidenhead, Berkshire, SL6 4UB, United Kingdom.

 

The Maidenhead facility will augment its current technological, clinical and administrative support of INC Research operations currently existing in Belgium, Bulgaria, Czech Republic, France, Germany, Hungary, Poland, Romania, Russia, Ukraine, Serbia and Montenegro, and Spain. INC Research’s DataSpectrum facility in Battle, United Kingdom has also expanded significantly to meet increased demand from European pharmaceutical and biotechnology customers seeking world-class data management, biostatistics and medical writing services. 

 

INC Research, through its dedicated INC Oncology® and INC CNS® divisions, manages all aspects of global clinical development programs for pharmaceutical and biotechnology companies developing treatments targeting cancer and central nervous system disorders.  In addition, INC Pediatrics™ offers specialized drug development services for products to treat neonatal, pediatric and adolescent illnesses.  Its INC DataSpectrum™ division provides a full range of data management, statistical analysis and medical writing services to support global drug development requirements for any therapeutic area.  INC Research has offices in North America and Western, Eastern and Central Europe.  For more information visit http://www.incresearch.com.

 

 

Kevan Nicholson

Last updated on: 27/08/2010 11:40:18

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.